Literature DB >> 89070

Duodenal glucagonoma: a case report.

V L Roggli, D M Judge, M H McGavran.   

Abstract

A case of a primary carcinoid islet cell tumor of the duodenum is reported, demonstrated by histochemistry, electron microscopy, and immunofluorescence to be composed of alpha cells containing glucagon-like material. The patient was found on admission to have hyperglycemia and a diffuse skin rash. Primary duodenal glucagonoma has not been previously reported.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89070     DOI: 10.1016/s0046-8177(79)80032-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Endoscopic findings of a pancreatic glucagonoma.

Authors:  A G Guirado; P Sanchez-Fayos; O Bosch; M J Relloso; C Rivas; J C Porres
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

Review 2.  Ectopic duodenal insulinoma: a very rare and challenging tumor type. Description of a case and review of the literature.

Authors:  Stefano La Rosa; Dario Pariani; Calogera Calandra; Alessandro Marando; Fausto Sessa; Ferdinando Cortese; Carlo Capella
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

3.  Duodenal enteroglucagonoma revealed by differential comparison of serum and tissue glucagon reactivity with Siemens' Double Glucagon Antibody and DakoCytomation's Polyclonal Rabbit Anti-Human Glucagon: a case report.

Authors:  Wesley B Vanderlan; Ziying Zhang; Marwan S Abouljoud
Journal:  J Med Case Rep       Date:  2010-06-15

Review 4.  Care for patients with multiple endocrine neoplasia type 1: the current evidence base.

Authors:  C R C Pieterman; M R Vriens; K M A Dreijerink; R B van der Luijt; G D Valk
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

Review 5.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.